Episode 30: Bayer's Sebastian Guth
from The Refill, by MM+M Hosted by The MM+M Podcast
Sebastian Guth was named president, Bayer Pharmaceuticals, Americas region, in December 2018. He talks with MM&M’s Marc Iskowitz about his first year in the role, where Bayer’s restocking its pipeline and how he plans to ramp up commercial activity before two big brands go off-patent. The episode concludes with a lightning round, during which Guth addresses the trend of big companies ditching their chief marketing officer (CMO) role, a job he held prior to taking his current position. Is your team still treating AI like a side experiment while competitors use it to win? Cut through the buzzword fatigue. On November 12th, join hundreds of top marketers in New York City for AI Deciphered, presented by Campaign, MM+M, and PRWeek. Get real-world playbooks from leaders like Reddit’s Rob Gaige and Yahoo’s Matt Sanchez across dedicated tracks built for daily execution. Check us out at: mmm-online.com Follow us: YouTube: @MMM-online TikTok: @MMMnews Instagram: @MMMnewsonline Twitter/X: @MMMnews LinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.
Embed this episode
What this episode covers
Sebastian Guth was named president, Bayer Pharmaceuticals, Americas region, in December 2018. He talks with MM&M’s Marc Iskowitz about his first year in the role, where Bayer’s restocking its pipeline and how he plans to ramp up commercial activity before two big brands go off-patent. The episode concludes with a lightning round, during which Guth addresses the trend of big companies ditching their chief marketing officer (CMO) role, a job he held prior to taking his current position.
No transcript yet.